MTOR and viral infectious disease: Consistent with our in vitro data, mice pre-treated with TORISEL had higher viral titers in both the skin (injection site) and muscle as compared to control mice, indicating that mTOR inhibition affects in vivo viral infection (Fig 2A and 2B).